“…Although the absolute number of new infections has been reduced in these regions, infections are most often observed in vaccinated infants born to HBV carrier mothers, suggesting that infants exposed to a maternal mutant virus may select for this strain during the development of vaccine-induced antibodies (39,89). An epidemiological model of the HBV that investigated possible patterns of emergence of a vaccine-resistant strain, showed that using pessimistic assumptions (i.e., the current vaccine provides no cross-immunity against the variant), the variant would not become dominant over the wild-type for at least 50 years (90).…”